Cited by 198Complement system in diseasesCoagulation, Bradykinin, Polyphosphates, and AngioedemaBiomarkers in Disease Mechanisms

Complement activation in factor D-deficient mice

Open access
Xu, Yuanyuan, Ma, Minghe, Ippolito, Gregory C., Schroeder, Harry W., Carroll, Michael C., Volanakis, John E.·2001·Proceedings of the National Academy of Sciences

Abstract

To assess the contribution of the alternative pathway in complement activation and host defense and its possible role in the regulation of systemic energy balance in vivo , factor D-deficient mice were generated by gene targeting. The mutant mice have no apparent abnormality in development and their body weights are similar to those of factor D-sufficient littermates. Complement activation could not be initiated in the serum of deficient mice by the alternative pathway activators rabbit erythrocytes and zymosan. Surprisingly, injection of cobra venom factor (CVF) caused a profound and reproducible reduction in serum C3 levels, whereas, as expected, there was no C3 reduction in factor B-deficient mice treated similarly. Studies of C3 and factor B activation in vitro by CVF demonstrated that in factor D-deficient serum the α chain of C3 was cleaved gradually over a period of 60 min without detectable cleavage of factor B. CVF-dependent C3 cleavage in the deficient serum required the presence of Mg 2+ , whereas in normal mouse serum the presence of divalent cations was not required. These results suggest that in mouse proteolytic cleavage of factor B by factor D is not an absolute requirement for the zymogen to active enzyme conformational transition of CVF-bound factor B. Kinetics of opsonization of Streptococcus pneumoniae by C3 fragments was much slower in factor D-deficient serum, suggesting a significant contribution of the alternative pathway to antibacterial host defense early after infection.

Integrity signals

Registry

Crossref · 10.1073/pnas.261428398

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Patients' cells showed increased mRNA levels of complement factor D (CFD).

    “In line with this finding, patients’ cells also showed increased mRNA levels of complement factor D (CFD), a component of the alternative complement pathway [147], which is involved in pathophysiological mechanisms of osteoarthritis and is considered as a potential predictive biomarker of joint pain in patients with hip and knee osteoarthritis [148,149,150].”

The citation lists haven’t been fetched yet

References 44 · Cited by 198

Authors
Xu, Y., Ma, M., Ippolito, G. C., Schroeder, H. W., Carroll, M. C., & Volanakis, J. E.
Affiliations
  • Harvard University (US)
  • Houston Methodist (US)
Venue
Proceedings of the National Academy of Sciences
Published
2001-11-27
Volume
98
Issue
25
Pages
14577-14582
ISSN
  • 0027-8424 (ISSN-L)
  • 1091-6490
OpenAlex
W2085796361
Cited by
198
References
44
Citations by year
2026: 3 · 2025: 12 · 2024: 13 · 2023: 6 · 2022: 13 · 2021: 12 · 2020: 6 · 2019: 11 · 2018: 8 · 2017: 8 · 2016: 9 · 2015: 5 · 2014: 10 · 2013: 9 · 2012: 5
FWCI
1.51
Type
journal article
Language
en
Open access
Locations
  • Proceedings of the National Academy of Sciences (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health (5r01ar044505-05)
  • National Institute of Allergy and Infectious Diseases (T32AI007051)
  • National Institute of Arthritis and Musculoskeletal and Skin Diseases (P60-AR20614, P60AR020614, AR44505)
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › Complement system in diseases
  • Health Sciences › Medicine › Genetics › Coagulation, Bradykinin, Polyphosphates, and Angioedema
  • Life Sciences › Immunology and Microbiology › Immunology › Biomarkers in Disease Mechanisms
Keywords
complement activation, alternative complement pathway, factor D, cobra venom factor, C3 cleavage, factor B, C3 fragments, opsonization, Streptococcus pneumoniae, host defense, energy balance
MeSH terms
Animals, Complement Pathway, Alternative, Complement C3, Elapid Venoms, Erythrocytes, Female, Kinetics, Magnesium, Male, Opsonin Proteins, Complement Factor B, Complement Factor D, Rabbits, Streptococcus pneumoniae, Zymosan, Mice, Knockout, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review